Altamira Therapeutics Ltd. - CYTO Earnings per share for the trailing year

Public company logo of Auris Medical (CYTO)

Altamira Therapeutics (CYTO) currently generates revenue through the sale of anti-allergen sprays and the implementation of RNA technologies. The company is expanding its internal potential via M&A transactions and the integration of the Peptide+ platform into partner projects. However, liquidity shortages and litigation are creating pressure, as evidenced by this GURU.Markets chart: the daily price action of the rolling annual EPS YoY indicates that the value of the metric is 5.50.

Altamira Therapeutics Ltd. (CYTO): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

CYTO (altamiratherapeutics.com): analytical breakdowns and indicator data

- stock price and consensus target price:
Fundamental valuation:Altamira Therapeutics Ltd (CYTO)
Mass-produced product of Altamira Therapeutics

This metric is calculated as the percentage deviation of current net earnings per share from the same value for the previous year. The metric measures the dynamics of the business's real earnings, allowing for an assessment of capital management efficiency. For Altamira Therapeutics (CYTO), this growth is driven by the low demand elasticity for the SemaPoly platform. Strong pricing power in the RNA delivery segment converts directly into profit. By analyzing the history of year-over-year EPS changes (TTM), an investor can determine the sustainability of this business model.

Competitor analysis for Altamira Therapeutics

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|cbdMD Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months PRFX|Lipella (LIPO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) pieris.com (PIRS)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months